Resources from the same session
Opening remarks
Presenter: Ross Soo
Session: Thermofisher Scientific and Janssen Pharmaceuticals - Riding the new waves of success: Latest strategies in the screening and management of NSCLC patients with EGFR exon 20 insertion mutations
Resources:
Webcast
Watching out for the tsunami: The burden of unmet need in advanced NSCLC patients with EGFR exon 20 insertion mutations
Presenter: Ross Soo
Session: Thermofisher Scientific and Janssen Pharmaceuticals - Riding the new waves of success: Latest strategies in the screening and management of NSCLC patients with EGFR exon 20 insertion mutations
Resources:
Webcast
Adjusting the sails in advanced NSCLC management: Treatment options for advanced NSCLC patients with EGFR exon 20 insertion mutations
Presenter: Byoung Chul Cho
Session: Thermofisher Scientific and Janssen Pharmaceuticals - Riding the new waves of success: Latest strategies in the screening and management of NSCLC patients with EGFR exon 20 insertion mutations
Resources:
Webcast
Panel discussion
Presenter: Ross Soo
Session: Thermofisher Scientific and Janssen Pharmaceuticals - Riding the new waves of success: Latest strategies in the screening and management of NSCLC patients with EGFR exon 20 insertion mutations
Resources:
Webcast
Closing remarks
Presenter: Ross Soo
Session: Thermofisher Scientific and Janssen Pharmaceuticals - Riding the new waves of success: Latest strategies in the screening and management of NSCLC patients with EGFR exon 20 insertion mutations
Resources:
Webcast